17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Accelerated Discovery of Carbamate Cbl-b Inhibitors Using Generative AI Models and Structure-Based Drug Design.
AstraZeneca
Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
China Pharmaceutical University
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b Inhibitors.
AstraZeneca
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).
China Pharmaceutical University
Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding.
Genentech
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity.
Astrazeneca
A Survey of Recently Discovered Naturally Occurring Organohalogen Compounds.
Dartmouth College
A concise review on marine bromopyrrole alkaloids as anticancer agents.
University of Kwazulu-Natal (Westville)
Sinularamides A-G, Terpenoid-Derived Spermidine and Spermine Conjugates with Casitas B-Lineage Lymphoma Proto-Oncogene B (Cbl-b) Inhibitory Activities from a
Yangzhou University
An affinity prediction approach for the ligand of E3 ligase Cbl-b and an insight into substrate binding pattern.
China Pharmaceutical University
TGF-ß INHIBITOR COMPOUND AND USE THEROF
Medinno Pharmaceutical Technology (Zhuhai) Co.
COMPOUND OF THE 7A,8,9,10,11,11A-HEXAHYDRO-1H,7H-PYRANO[2,3-C]XANTHENE TYPE, METHOD OF PREPARATION THEREOF, INTERMEDIATES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF
Center National De La Recherche Scientifique